SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208,000 | +47.5% | 7,494 | +59.7% | 0.00% | – |
Q2 2023 | $141,000 | -8.4% | 4,692 | +9.6% | 0.00% | – |
Q1 2023 | $154,000 | -52.6% | 4,282 | -53.0% | 0.00% | – |
Q4 2022 | $325,000 | +151.9% | 9,103 | +139.6% | 0.00% | – |
Q3 2022 | $129,000 | +207.1% | 3,799 | +159.5% | 0.00% | – |
Q2 2022 | $42,000 | -68.4% | 1,464 | -64.5% | 0.00% | – |
Q1 2022 | $133,000 | -49.2% | 4,127 | -54.2% | 0.00% | – |
Q4 2021 | $262,000 | +67.9% | 9,020 | +54.8% | 0.00% | – |
Q3 2021 | $156,000 | +13.0% | 5,825 | +29.7% | 0.00% | – |
Q2 2021 | $138,000 | +100.0% | 4,491 | +69.0% | 0.00% | – |
Q1 2021 | $69,000 | -86.8% | 2,658 | -87.2% | 0.00% | – |
Q4 2020 | $522,000 | +21.7% | 20,755 | +0.8% | 0.00% | – |
Q3 2020 | $429,000 | -13.5% | 20,596 | -1.3% | 0.00% | – |
Q2 2020 | $496,000 | +30.2% | 20,873 | -1.5% | 0.00% | – |
Q1 2020 | $381,000 | +765.9% | 21,181 | +1024.3% | 0.00% | – |
Q4 2019 | $44,000 | -34.3% | 1,884 | -23.2% | 0.00% | – |
Q3 2019 | $67,000 | -92.6% | 2,453 | -91.0% | 0.00% | – |
Q2 2019 | $901,000 | -6.1% | 27,233 | -0.6% | 0.00% | – |
Q1 2019 | $960,000 | +13.2% | 27,402 | +7.4% | 0.00% | – |
Q4 2018 | $848,000 | -35.2% | 25,511 | -1.9% | 0.00% | -100.0% |
Q3 2018 | $1,308,000 | -25.3% | 25,999 | -11.2% | 0.00% | 0.0% |
Q2 2018 | $1,752,000 | +57.0% | 29,274 | +20.1% | 0.00% | 0.0% |
Q1 2018 | $1,116,000 | +17.7% | 24,371 | +2.3% | 0.00% | – |
Q4 2017 | $948,000 | -9.4% | 23,820 | -8.9% | 0.00% | -100.0% |
Q3 2017 | $1,046,000 | -91.1% | 26,146 | -90.4% | 0.00% | -83.3% |
Q2 2017 | $11,699,000 | +1126.3% | 271,451 | +790.8% | 0.01% | +500.0% |
Q1 2017 | $954,000 | +24.9% | 30,473 | +0.7% | 0.00% | – |
Q4 2016 | $764,000 | +51.0% | 30,251 | +47.7% | 0.00% | – |
Q3 2016 | $506,000 | +29.7% | 20,475 | +7.0% | 0.00% | – |
Q2 2016 | $390,000 | +16.4% | 19,136 | -12.8% | 0.00% | – |
Q1 2016 | $335,000 | +93.6% | 21,946 | +70.9% | 0.00% | – |
Q4 2015 | $173,000 | +16.1% | 12,842 | +20.7% | 0.00% | – |
Q3 2015 | $149,000 | -24.0% | 10,636 | -7.6% | 0.00% | – |
Q2 2015 | $196,000 | +8.3% | 11,505 | -44.6% | 0.00% | – |
Q3 2014 | $181,000 | -35.6% | 20,781 | -19.0% | 0.00% | – |
Q2 2014 | $281,000 | – | 25,668 | +256580.0% | 0.00% | – |
Q2 2013 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |